Focused remedy momelotinib gives important symptom and anemia enhancements in sufferers with myelofibrosis

Sufferers with myelofibrosis had clinically important enchancment in disease-related signs, together with anemia and spleen enlargement, when handled with the focused remedy momelotinib, in response to new outcomes.